chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, SARS-CoV-2 test
Clinical narrative: Dizziness when moving head quickly; Headache; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the left arm on 01May2021 at 17:15 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic migraines and allergy to bananas (oral allergy) and raw pineapple (oral allergy). Concomitant medications included omeprazole (MANUFACTUERER UNKNOWN), colecalciferol (VITAMIN D3), folic acid (MANUFACTURER UNKNOWN) and L-theanine (MANUFACTURER UNKNOWN); all taken for unknown indications from unknown dates and unknown if ongoing. The patient previously received loratadine (CLARITIN) and amoxicillin (MANUFACTURER UNKNOWN) on an unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient experienced headache everyday from 10May2021 to 18May2021. The patient also experienced dizziness when moving head quickly on same dates as headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient underwent lab test on 18May2021 which included COVID test via nasal swab and the test result was negative. Therapeutic measures were taken as a result of the events headache and dizziness when moving head quickly which included treatment with acetaminophen (TYLENOL) 500 mg twice a day. The clinical outcome of the events headache and dizziness when moving head quickly were recovered on 18May2021.   No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Chills, Decreased appetite, Fatigue, Headache
Clinical narrative: Fever; Chills; Headache; Fatigue; Appetite lost; loss of taste; Drowsiness; sore left arm (site of injection); random sharp pains; This is a spontaneous report from a non-contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: EW0185) via an unspecified route of administration on the left arm on 17May2021 at 12:00(at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history included gallbladder disease. Concomitant medications included vitex agnus-castus (CHASTE TREE), doxycycline (MANUFACTURER UNKNOWN) and vitamins nos, minerals nos, herbal nos (HERBAL NOS;MINERALS NOS;VITAMINS NOS)all from an unknown date for unknown indication The patient previously took Cefadroxil for unknown indication and unknown date and and experienced drug allergy . The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 26Apr2021 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17May2021 at 22:00 the patient experienced Fever, chills, headache, fatigue, random sharp pains, loss of appetite, some loss of taste, drowsiness, sore left arm (site of injection). No therapeutic measures were taken as a result of the events. The clinical outcome of the events Fever, chills, headache, fatigue, random sharp pains, loss of appetite, some loss of taste, drowsiness, sore left arm (site of injection)were recovered on an unknown date in May2021  No follow-up attempts are possible. No further information expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Somnolence, Vaccination site pain
Clinical narrative: Fever; Chills; Headache; Fatigue; Appetite lost; loss of taste; Drowsiness; sore left arm (site of injection); random sharp pains; This is a spontaneous report from a non-contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: EW0185) via an unspecified route of administration on the left arm on 17May2021 at 12:00(at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history included gallbladder disease. Concomitant medications included vitex agnus-castus (CHASTE TREE), doxycycline (MANUFACTURER UNKNOWN) and vitamins nos, minerals nos, herbal nos (HERBAL NOS;MINERALS NOS;VITAMINS NOS)all from an unknown date for unknown indication The patient previously took Cefadroxil for unknown indication and unknown date and and experienced drug allergy . The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 26Apr2021 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17May2021 at 22:00 the patient experienced Fever, chills, headache, fatigue, random sharp pains, loss of appetite, some loss of taste, drowsiness, sore left arm (site of injection). No therapeutic measures were taken as a result of the events. The clinical outcome of the events Fever, chills, headache, fatigue, random sharp pains, loss of appetite, some loss of taste, drowsiness, sore left arm (site of injection)were recovered on an unknown date in May2021  No follow-up attempts are possible. No further information expected.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Vaccination site pain
Clinical narrative: injection site pain; headache; fatigue; muscle pain; This is a spontaneous report from a non-contactable consumer, the patient. A 19-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0179), via an unspecified route of administration in the left arm on 18May2021 at 09:15 (at the age of 19-years-old) as a single dose for COVID-19 immunisation. Medical history reported as none. The patient did not take any concomitant medication. The patient did not have any allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EW0162), via an unspecified route of administration in the left arm on 27Apr2021 at 09:15 as a single dose for COVID-19 immunisation. On 18May2021 at 12:00, the patient experienced injection site pain, headache, fatigue and muscle pain. On 15May2021, the patient underwent saliva covid test and the result was found to be negative. No therapeutic measures were taken as the result of adverse events. The adverse event did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcomes of the events injection site pain, headache, fatigue and muscle pain was recovering at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation delayed
Clinical narrative: Haven't gotten menstrual period; This is a spontaneous report from a non-contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 30Mar2021 (at the age of 26-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021, the patient reported that since she was 14 years old, she had a menstrual period every month without fail, now all of a sudden since getting vaccinated she had not gotten one menstrual period. Therapeutic measures were not taken as a result of this event. The clinical outcome of the event menstruation delay was not recovered at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Vomiting
Clinical narrative: Severe Nausea; Vomiting; This is a spontaneous report from a non-contactable consumer, the patient. A 12-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date in May2021 at 15:00 (at the age of 12-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Concomitant medications were not reported. The patient did not have a history of allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in May2021 at 22:00, the patient experienced severe nausea accompanied by a vomiting event. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe nausea accompanied by a vomiting event was resolved on an unknown date in 2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Came down with a bad case of shingles 4 days after getting vaccination.; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 28Mar2021 at 12:30 (at the age of 42-years-old) as a single dose for COVID-19 immunization. The patient has not reported any other health issues. The patient did not have any allergies to food, medications, or other products. Concomitant therapy was reported as none. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other medications or vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of COVID vaccine. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 06Mar2021 at 14:30 (at the age of 42-years-old), as a single dose for COVID-19 immunization. On 31Mar2021 at 12:00, 3 days after the vaccination the patient had come down with a bad case of shingles. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of shingles and included treatment with steroids, creams, anti-viral medications. The clinical outcome of the event shingles was recovered on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms, Myalgia
Clinical narrative: sore muscles; muscle spasms; This is a spontaneous report from a non-contactable other healthcare professional, the patient. A 19-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications were not reported. The patient experienced sore muscles and muscle spasms on an unknown date. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. No therapeutic measures were taken as the result of adverse event. The clinical outcome of the events sore muscles and muscle spasms was unknown at the time of report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Headache, Nausea, Pain
Clinical narrative: headache; felt nauseous; felt weak; body pain; This is a spontaneous report from a non-contactable healthcare professional, the patient. A 30-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172), via an unspecified route of administration in the left arm on 12May2021 at 16:00 (at the age of 30-year-old), as a single dose for COVID-19 immunisation. Medical history was reported as none and the patient did not have a history of allergies to any food or medications or other products. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 13May2021 at 09:30, morning after the day of vaccination the patient experienced headache, felt nauseous, felt weak and experienced body pain. No therapeutic measures were taken for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event headache, felt nauseous, felt weak and body pain was recovered on an unknown date in May2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal distension, Abdominal pain, Paraesthesia, Vaginal haemorrhage
Clinical narrative: Vaginal spotting; abd bloating; abd cramping; Tingling in body- fingers/toes, radiating up her body, felt like she could not breathe; This is a spontaneous report from a contactable physician. A 49-years-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an intramuscular route of administration on 26Mar2021 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not receive any concomitant medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an intramuscular route of administration on 26Mar2021 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021 the patient experienced vaginal spotting, abd bloating, abd cramping and tingling. The clinical course was reported as follows: Vaginal spotting and abd bloating that started shortly after 2nd shot, now for 1 month, abd cramping more recently, Tingling in body- fingers/toes, radiating up patient's body, felt like she could not breathe. The events resulted in emergency room/department visits or urgent care and physician visit. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events vaginal spotting, abd bloating, abd cramping, the tingling was resolving at the time of the report.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Ear swelling, Eye swelling, Headache, Lacrimation increased, Pain in jaw
Clinical narrative: 6 itchy spots between arm and right shoulder.; pain in right jaw; swelling on right side of face/ear; swelling on right side of face/ear; right eye swollen and leaking; right eye swollen and leaking; severe pain around my head (felt like rubber bands tightening); This is a spontaneous report from a contactable consumer, the patient. A 78-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 6201) via an unspecified route of administration in the right arm on 25Feb2021 at 11:00 as a single dose for COVID-19 immunisation. Medical history included 5 stents and allergy to penicillin. Concomitant medications included ASPIRIN 81, ATORVASTATIN, ezetimibe, LISINOPRIL, and primi. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 9809) via an unspecified route of administration in the right arm on 04Feb2021 at 10:30 as a single dose for COVID-19 immunisation and also experienced drug allergy to amoxicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On an unknown date in Mar2021, the patient experienced 6 itchy spots between arm and right shoulder, pain in right jaw, swelling on right side of face and ear, right eye swollen, and leaking and severe pain around head (which felt like rubber bands tightening). The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with unspecified medication. The clinical outcome of the events 6 itchy spots between arm and right shoulder, pain in right jaw, swelling on right side of face and ear, right eye swollen and leaking and severe pain around head (which felt like rubber bands tightening) were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Swelling face
Clinical narrative: 6 itchy spots between arm and right shoulder.; pain in right jaw; swelling on right side of face/ear; swelling on right side of face/ear; right eye swollen and leaking; right eye swollen and leaking; severe pain around my head (felt like rubber bands tightening); This is a spontaneous report from a contactable consumer, the patient. A 78-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 6201) via an unspecified route of administration in the right arm on 25Feb2021 at 11:00 as a single dose for COVID-19 immunisation. Medical history included 5 stents and allergy to penicillin. Concomitant medications included ASPIRIN 81, ATORVASTATIN, ezetimibe, LISINOPRIL, and primi. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 9809) via an unspecified route of administration in the right arm on 04Feb2021 at 10:30 as a single dose for COVID-19 immunisation and also experienced drug allergy to amoxicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On an unknown date in Mar2021, the patient experienced 6 itchy spots between arm and right shoulder, pain in right jaw, swelling on right side of face and ear, right eye swollen, and leaking and severe pain around head (which felt like rubber bands tightening). The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with unspecified medication. The clinical outcome of the events 6 itchy spots between arm and right shoulder, pain in right jaw, swelling on right side of face and ear, right eye swollen and leaking and severe pain around head (which felt like rubber bands tightening) were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pyrexia, SARS-CoV-2 test, Vomiting
Clinical narrative: Fever 72 hours; Muscle aches; Chills; Vomiting; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 09May2021 at 09:00 (at the age of 16-year-old) as a single dose for COVID-19 immunisation. Medical history included autism and attention deficit hyperactivity disorder (ADHD). The patient did not have any allergies to food, medications, or other products. Concomitant medication included  dexmethylphenidate (MANUFACTURER UNKNOWN) from an unknown date, for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. On 09May2021 at 23:00, the patient experienced fever 72 hours, muscle aches, chills and vomiting. The events resulted in doctor or other healthcare professional office/clinic visit. On 12May2021, the patient underwent nasal swab and the result was negative. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event fever was recovered on 12May2021. The clinical outcome of the events muscle aches, chills and vomiting were recovered on an unknown date in May2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: Painful node in left armpit; Enlarged node in left armpit; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0178) via an unspecified route of administration in the left arm on 19May2021 at 15:30 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. Medical history included depression, GERD (gastroesophageal reflux disease), hypothyroidism and obstructive sleep apnea. Patient has allergy to penicillin. Concomitant medications included fluoxetine (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN) and pantoprazole sodium sesquihydrate (PROTONIX) all for unknown indications from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left arm on 28Apr2021 at 15:00 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 20May2021 at 03:00, the patient experienced enlarged and painful node in left armpit. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the adverse events. The clinical outcome of enlarged and painful node in left armpit was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pyrexia
Clinical narrative: Fever; Chills; Tired; This is a spontaneous report from a contactable consumer or non health professional. A patient of unspecified age and gender received bnt162b2 (COMIRNATY, Solution for injection, Batch/Lot number: not reported), via an unspecified route of administration on an unspecified date as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. Medical history and concomitant medications were not reported. On an unspecified date, the patient experienced fever, chills and tired. Outcome of the events were unknown.  Information on the lot/batch number has been requested. No follow-up attempts are completed; information about lot/batch number cannot be obtained.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain, Throat irritation, Vomiting
Clinical narrative: vomiting; chills; body aches; extremely tired; throat was burning; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0168) via an unspecified route of administration in the left arm on 18May2021 at 17:30 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The patient had no health conditions or medications. The patient had no known allergies. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20May2021 at 05:30, 36 hours after the shot, the patient woke up and started vomiting. The patient was unable to drink water or eat for 4 hours without vomiting. The patient also had chills, body aches, and was extremely tired. The patient rarely got sick and vomited so much that her throat was burning. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events vomiting, chills, body aches, extremely tired and throat was burning were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Maternal exposure during breast feeding, Pyrexia
Clinical narrative: I had flu like symptoms for 3-4 days, I also nurse a 9 month old me due to latch issues he ingested some of my blood. Day two or 3 after my shot he had a fever and was fatigued.; I had flu like symptoms for 3-4 days, I also nurse a 9 month old me due to latch issues he ingested some of my blood. Day two or 3 after my shot he had a fever and was fatigued.; I had flu like symptoms for 3-4 days, I also nurse a 9 month old me due to latch issues he ingested some of my blood. Day two or 3 after my shot he had a fever and was fatigued.; This is a spontaneous report from a contactable consumer (parent). A 09-month-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: solution for injection, Lot number: not reported), dose 2 via an unspecified route of administration, administered in arm right on 20Apr2021 at 15:45 as DOSE 2, SINGLE for covid-19 immunisation at Pharmacy or Drug Store. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: solution for injection, Lot number: not reported), dose 1 via an unspecified route of administration, on 30Mar2021 at 03:45 PM as DOSE 1, SINGLE for covid-19 immunisation and the patient experienced flu after first shot. The patient medical history was not reported. There were no concomitant medications reported. The patient was not administered any other vaccine four weeks prior to the vaccination. Other medications in two weeks was reported as no. Patient did not have covid prior vaccination and had not been tested for covid post vaccination. She (mother) had no known allergies or other medical history. On 21Apr2021 at 04:00 AM, It was reported that, I had flu like symptoms for 3-4 days, I also nurse a 9-month-old me due to latch issues he ingested some of my blood, day two or 3 after my shot he had a fever and was fatigued. Patient did not receive any treatment for the events. Outcome of all the events were recovered in 2021.  Information on the lot/batch number has been requested.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Erythema, Localised infection, Peripheral swelling, SARS-CoV-2 test
Clinical narrative: Arm became infected with blisters in center. Red, warm, swollen; Arm became infected with blisters in center. Red, warm, swollen; Arm became infected with blisters in center. Red, warm, swollen; Arm became infected with blisters in center. Red, warm, swollen; Arm became infected with blisters in center. Red, warm, swollen; This is a spontaneous report from a contactable consumer or other non-Health Care Professional.A 63-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EW1067 and Expiry date: Unknown), dose 1 via an unspecified route of administration, administered in Arm Right on 12May2021 13:00at the age of 63-years-old as DOSE 1, SINGLE for Covid-19 immunization. Medical history included immune system disorder from an unknown date and unknown if ongoing, hypersensitivity from an unknown date and unknown if ongoing, covid-19 from an unknown date Concomitant medication(s) included immunoglobulin human normal (GAMMAGARD SD) taken for an unspecified indication, start and stop date were not reported. The patient was diagnosed with Covid 19 and was not tested for Covid-19 Since the vaccination. On 14May2021 the patient experienced arm became infected with blisters in center. red, warm, swollen. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on an unspecified date. Therapeutic measures were taken as a result of arm became infected with blisters in center. red, warm, swollen, arm became infected with blisters in center treatment included told to put hydrcodicene on it. The outcome of events was recovering.  No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Skin warm
Clinical narrative: Arm became infected with blisters in center. Red, warm, swollen; Arm became infected with blisters in center. Red, warm, swollen; Arm became infected with blisters in center. Red, warm, swollen; Arm became infected with blisters in center. Red, warm, swollen; Arm became infected with blisters in center. Red, warm, swollen; This is a spontaneous report from a contactable consumer or other non-Health Care Professional.A 63-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EW1067 and Expiry date: Unknown), dose 1 via an unspecified route of administration, administered in Arm Right on 12May2021 13:00at the age of 63-years-old as DOSE 1, SINGLE for Covid-19 immunization. Medical history included immune system disorder from an unknown date and unknown if ongoing, hypersensitivity from an unknown date and unknown if ongoing, covid-19 from an unknown date Concomitant medication(s) included immunoglobulin human normal (GAMMAGARD SD) taken for an unspecified indication, start and stop date were not reported. The patient was diagnosed with Covid 19 and was not tested for Covid-19 Since the vaccination. On 14May2021 the patient experienced arm became infected with blisters in center. red, warm, swollen. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on an unspecified date. Therapeutic measures were taken as a result of arm became infected with blisters in center. red, warm, swollen, arm became infected with blisters in center treatment included told to put hydrcodicene on it. The outcome of events was recovering.  No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Pain in extremity, Pyrexia
Clinical narrative: Fever 99.5 the next day; Sore arm; Occasionally felt fatigue, tired; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 12May2021 at 13:15 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. The patients' medical history was reported as none. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. Concomitant medications included benazepril (MANUFACTURER UNKNOWN) for an unspecified indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 21Apr2021 at 10:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 12May2021, the patient experienced sore arm for three days and the patient occasionally felt fatigue, tired for about 2-3 hours which would then wear off. On 13May2021, the next day of the vaccination, the patient experienced a fever of 99.5 (unspecified units). Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event fever 99.5 (unspecified units) the next day and felt fatigue, tired was resolving at the time of this report. The clinical outcome of the event sore arm was resolved on 15May2021.  No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Cold sweat, Diarrhoea, Fatigue, Headache, Injection site induration
Clinical narrative: bad headache; cold sweats; nausea; diarrhea; swollen glands; weird taste in the mouth; Could not lift arm at all; Pustule rash on forehead face and behind the ears; Soreness and hard at injection site 2 days post; Lots of fatigue for the first two weeks to the point where I wanted to fall asleep in traffic.; Soreness and hard at injection site 2 days post; This is a spontaneous report from a contactable healthcare professional, the patient. A 55-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO176) via an unspecified route of administration in the right arm on 30Apr2021 at 12:00 (at the age of 55-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included estradiol (MANUFACTURER UNKNOWN), probiotics (MANUFACTURER UNKNOWN), colecalciferol (VITAMIN D3), multivitamin (MANUFACTURER UNKNOWN) and others. The patient previously took cefdinir and experienced allergy to it. On 02May2021 at 12:00, he patient experienced pustule rash on forehead face and behind the ears two days post (until this week). The patient also experienced soreness and hard at injection site two days post vaccination, could not lift arm at all (five days post vaccination), weird taste in mouth (1 week post and ongoing until today), cold sweats, nausea, diarrhea and swollen glands (12 days post vaccination), bad headache (13 days post vaccination) with swollen glands, lots of fatigue (for the first two weeks to the point where the patient wanted to fall asleep in traffic).  Only thing at the time of report was weird taste is still off and on (NOT metallic). Therapeutic measures were not taken as a result of the events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome for the events pustular rash, soreness and hard at injection site, could not lift arm at all, weird taste in mouth, cold sweat, nausea, diarrhea, bad headache, swollen glands and fatigue was recovering at the time of this report. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the right arm on 21May2021 at 12:00 (at the age of 55-year-old) as a single dose for COVID-19 immunisation.  Follow-up attempts completed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Loss of personal independence in daily activities, Lymphadenopathy, Nausea, Rash pustular, Taste disorder
Clinical narrative: bad headache; cold sweats; nausea; diarrhea; swollen glands; weird taste in the mouth; Could not lift arm at all; Pustule rash on forehead face and behind the ears; Soreness and hard at injection site 2 days post; Lots of fatigue for the first two weeks to the point where I wanted to fall asleep in traffic.; Soreness and hard at injection site 2 days post; This is a spontaneous report from a contactable healthcare professional, the patient. A 55-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO176) via an unspecified route of administration in the right arm on 30Apr2021 at 12:00 (at the age of 55-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included estradiol (MANUFACTURER UNKNOWN), probiotics (MANUFACTURER UNKNOWN), colecalciferol (VITAMIN D3), multivitamin (MANUFACTURER UNKNOWN) and others. The patient previously took cefdinir and experienced allergy to it. On 02May2021 at 12:00, he patient experienced pustule rash on forehead face and behind the ears two days post (until this week). The patient also experienced soreness and hard at injection site two days post vaccination, could not lift arm at all (five days post vaccination), weird taste in mouth (1 week post and ongoing until today), cold sweats, nausea, diarrhea and swollen glands (12 days post vaccination), bad headache (13 days post vaccination) with swollen glands, lots of fatigue (for the first two weeks to the point where the patient wanted to fall asleep in traffic).  Only thing at the time of report was weird taste is still off and on (NOT metallic). Therapeutic measures were not taken as a result of the events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome for the events pustular rash, soreness and hard at injection site, could not lift arm at all, weird taste in mouth, cold sweat, nausea, diarrhea, bad headache, swollen glands and fatigue was recovering at the time of this report. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the right arm on 21May2021 at 12:00 (at the age of 55-year-old) as a single dose for COVID-19 immunisation.  Follow-up attempts completed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: bad headache; cold sweats; nausea; diarrhea; swollen glands; weird taste in the mouth; Could not lift arm at all; Pustule rash on forehead face and behind the ears; Soreness and hard at injection site 2 days post; Lots of fatigue for the first two weeks to the point where I wanted to fall asleep in traffic.; Soreness and hard at injection site 2 days post; This is a spontaneous report from a contactable healthcare professional, the patient. A 55-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO176) via an unspecified route of administration in the right arm on 30Apr2021 at 12:00 (at the age of 55-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included estradiol (MANUFACTURER UNKNOWN), probiotics (MANUFACTURER UNKNOWN), colecalciferol (VITAMIN D3), multivitamin (MANUFACTURER UNKNOWN) and others. The patient previously took cefdinir and experienced allergy to it. On 02May2021 at 12:00, he patient experienced pustule rash on forehead face and behind the ears two days post (until this week). The patient also experienced soreness and hard at injection site two days post vaccination, could not lift arm at all (five days post vaccination), weird taste in mouth (1 week post and ongoing until today), cold sweats, nausea, diarrhea and swollen glands (12 days post vaccination), bad headache (13 days post vaccination) with swollen glands, lots of fatigue (for the first two weeks to the point where the patient wanted to fall asleep in traffic).  Only thing at the time of report was weird taste is still off and on (NOT metallic). Therapeutic measures were not taken as a result of the events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome for the events pustular rash, soreness and hard at injection site, could not lift arm at all, weird taste in mouth, cold sweat, nausea, diarrhea, bad headache, swollen glands and fatigue was recovering at the time of this report. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the right arm on 21May2021 at 12:00 (at the age of 55-year-old) as a single dose for COVID-19 immunisation.  Follow-up attempts completed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Amnesia
Clinical narrative: All of a sudden could not remember who I was, or what I was doing, as if I had total amnesia. I kept looking around wondering what was going on, I had NO idea. it was really scary.; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0168) via an unspecified route of administration in the arm left on 18May2021 at 10:45 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Relevant medical history included unspecified condition and penicillin allergy. The patient received other medicines (unspecified) within two weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID -19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19May2021 at 12:00, when the patient was at work and all of a sudden could not remember who he was, or what he was doing, as if had total amnesia, this went on for about an hour, kept looking around wondering what was going on, the patient had NO idea. It was really scary. The patient would realize then what he was doing, and it would happen again, it was like would wake up, and not know where patient was, but was awake the whole time. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event all of a sudden could not remember was resolved on an unknown date in May2021.  No follow-up attempts are needed. No further information is expected.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Increased appetite, Myalgia
Clinical narrative: appetite gain; muscle pain; This is a spontaneous report from a non-contactable consumer, the patient. A 20-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 20May2021 at 14:15 (at the age of 20-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included bupropion hydrochloride (WELLBUTRIN) from unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20May2021 at 14:45, the patient experienced muscle pain and appetite gain. The patient did not receive any treatment for the reported events. The clinical outcome of the events muscle pain and appetite gain were not recovered at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: left leg went numb; tingling; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 21May2021 at 11:15(at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history included heart disorder, asthma and allergy to penicillin. The patient did not receive any other medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 21May2021 at 13:15, within 2 hours of the shot all of a sudden, the patient experienced left leg went numb and tingling. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the events left leg went numb and tingling were unknown at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.